Rebuffed by a federal jury verdict, Mycogen Corp. now faces the prospect of competing head on against Monsanto in the open market for Bt crops.

The U.S. District Court jury in Delaware last week rejected the company's bid to change the competitive landscape via litigation, finding that two of MYCO's patents covering the Bt toxin gene in plants are invalid.